Concepedia

Qianfeng Shi

QS

Statistics

Publications

5

Citations

588

H-Index

5

Active since

2018

Affiliations

Sun Yat-sen Memorial Hospital(Current)

Sun Yat-sen University

The First Affiliated Hospital, Sun Yat-sen University

Qianfeng Shi is an author at Sun Yat-sen Memorial Hospital specializing in oncology, molecular oncology, and breast cancer resistance mechanisms.

Publications per year

2018–2022

5

Publications

5

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Qianfeng Shi, Yudong Li, Shunying Li et al. · Nature Communications · 2020 · 194 citations · Full text

, , +15

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

Yinghua Zhu, Yujie Liu, Chao Zhang et al. · Nature Communications · 2018 · 193 citations · Full text

, , +17

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Zijie Cai, Jingru Wang, Yudong Li et al. · Science China Life Sciences · 2022 · 106 citations

, , +17

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

Shunying Li, Hongna Lai, Jieqiong Liu et al. · JCO Precision Oncology · 2020 · 75 citations · Full text

, , +17

LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP

Hongna Lai, Rui Wang, Shunying Li et al. · Science China Life Sciences · 2019 · 20 citations

, , +14

1–5 of 5